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We present a case of an organ conﬁned urinary bladder paraganglioma and concomitant metastatic lung
cancer to the liver diagnosed on a 66 year old man initially though to be metastatic bladder cancer. The
patient was referred to our hospital for frank hematuria and a single solid bladder tumor was identiﬁed
at ﬂexible cystoscopy. We are also reviewing the literature on the diagnostic and therapeutic approach of
extra-adrenal phaeochromocytoma.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Extra-adrenal phaeochromocytoma (paraganglioma) of the
urinary bladder is a rare clinical entity, accounting for less than
0.05% of all bladder tumors.1
It also comprises 10% of all extra-adrenal phaeochromocytomas.2
35% of these tumors are malignant. They develop in the para-
ganglion chromafﬁn tissue of the nervous system.
There are very weak data to support familial predisposition.
Common symptomatology in patients with bladder para-
ganglioma includes hematuria and intermittent hypertension dur-
ing urination, along with generalized symptoms due to increased
levels of catecholamines.
Serum and urine catecholamine levels are considered to be the
most appropriate tests for diagnosing catecholamine-secreting
paragangliomas.
Additionally, measurement of an epinephrine metabolite, the
free serum metanephrines level, has the best validity for dis-
tinguishing a phaeochromocytoma from a functional
paraganglioma.3
However, almost a third of bladder paraganglioma patients do
not present with tumor speciﬁc symptomatology.
Histological features of the tumor are the same as in para-
ganglioma of other organs, including adrenal pheochromocytoma.
The large, polyhedral, pleomorphic, chromafﬁn tumor cells grow inTsafrakidis).
Inc. This is an open access article ua “zellballen” pattern and are embedded in a ﬁbrous network that is
rich with blood vessels. Malignant features cannot be distinguished
and the only proof of metastasis can be provided from imaging
investigations.
The most appropriate imaging modalities for the diagnosis of
urinary bladder paraganglioma is the CT and the MRI scans4,5 but
due to its rare prevalence in urinary bladder malignancies speciﬁc
imaging and hematological tests are often not performed leading to
unexpected and occasionally serious intra-operative morbidity.
In our case transurethral complete and uneventful resection of
the tumor was performed. We are presenting the case and
reviewing the international literature on this rare subject.Our case
A 66 year old man presented with a single episode of hematuria
to the AnE department.
Clinical examination was unremarkable.
All blood test including full blood count and urea and electro-
lytes came back normal.
His medical history included hypercholesterolemia, hyperten-
sion and moderate to severe aortic stenosis with good left ven-
tricular function.
He also had a 15 pack per year smoking history but quit smoking
35 years ago.
He denied any previous major abdominal or pelvic surgery.
He underwent a ﬂexible cystoscopy, a contrast CT scan of the
thorax, abdomen and pelvis and a urine cytology test as per pro-
tocol of hematuria investigation in our unit. The ﬂexible cystoscopynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 2. CT contrast image of the right lung adenocarcinoma.
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showed a bladder lesion as ﬁlling defect (Fig. 1) and a upper lobe
5 cm mass of the right lung (Fig. 2) with some cavitation accom-
panied by right hilar and subcarinal lymphadenopathy and at least
3 liver lesions, very suspicious for liver metastases.
The patient then underwent complete transurethral resection of
the bladder tumor and had a normal recovery.
Surprisingly, histology report of the bladder tumor showed
paraganglioma.
The sample included deep muscle which was not involved in the
tumor.
The lamina propria was inﬁltrated by nests of eccentric nuclei.
Mitoses were inconspicuous (Ki67 index <1%) and the nests of
cells were surrounded by delicate vascular network. The cells were
strongly positive for CD56, synaptophysin and chromograninwith a
surrounding network of S100 positive cells (Fig. 3). Cells were
negative for CAM 5.2 and CD68.
The additional ﬁnding of lung lesions had been discussed in the
local lung multi-disciplinary team meeting, where CT guided liver
lesions biopsies were recommended.
Unfortunately, the pathology of the liver biopsies showed met-
astatic lung adenocarcinoma. He was treated with palliative
chemotherapy.Discussion
Urinary bladder paraganglioma is a very rare clinical entity. It
mostly represents a benign tumor and the majority of para-
gangliomas are considered to be hormonally active.
However, clinical suspicion at the time of patient presentation is
low and therefore all tumor-speciﬁc biochemical (catecholamines
and free serum metanephrine levels) and imaging investigations
(Iodine metaiodinebenzylguinidine scintigraphy [MIBG]) are not
necessarily offered. However, serum catecholamines levels, should
offered, are not necessarily related to malignancy potential.3
For imagingmodalitieswith greater precision, if in doubt, positron
emission tomography (PET) scanning with 18F-ﬂuorodeoxyglucose,
11C-hydroxyephedrine and 6-18F-ﬂuorodopamine can be offered. In
our case they were not performed.
Our patient was asymptomatic apart from the presence of frank,
painless hematuria. Therewere no speciﬁc investigations requested
for the patient except from urgent ﬂexible cystoscopy and a CT
urogram which showed suspicion of metastatic bladder cancer.Figure 1. CT contrast image of the solid bladder tumor.Tumor speciﬁc cystoscopic features of paraganglioma are not yet
established in bibliography.
Diagnosis was set by histological examination.
The patient did not develop any intra-operative complications
and urinary tract recovery was normal following complete resec-
tion of the tumor.
With regard to treatment options for organ conﬁned disease,
complete surgical excision is the treatment of choice. This may
entail transurethral resection or partial cystectomy.
For benign lesions 5-year survival is excellent and estimated at
95%.
Data on metastatic paraganglioma are sparse as no large series
of long-term follow up can be found in current literature. A com-
bination of radiotherapy, palliative chemotherapy and surgical
excision is recommended. As far as theurapeutic agents are con-
cerned, chemotherapeutic agents such as cyclophosphamide,
dacarbazine and vincristine are some of the most preferable.
For late stage bonemetastases, I-labeled-MIBG can be offered for
symptom palliation.
Further research on this subject is warranted.Figure 3. S-100 immunohistological staining image of bladder paraganglioma (200).
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